CYCN (CYCN) Stock Price & Analysis
CYCN (CYCN) fell 14.31% to USD 4.25 as of September 8, 2026 at 06:23 UTC, according to Nexqual real-time market data.
CYCN last closed at USD 4.25; the session ranged USD 4.08–4.53 on volume of 101,693 shares. Market capitalization is —, with a 52-week range of USD 1.03–8.48 (NCM). Source: Nexqual, September 8, 2026 at 06:23 UTC.
Key Statistics (as of September 8, 2026 at 06:23 UTC)
| Price | USD 4.25 |
|---|---|
| Change | ▼ 14.31% (down) |
| Previous Close | USD 4.25 |
| Open | USD 4.25 |
| Day Range | USD 4.08 – 4.53 |
| 52-Week Range | USD 1.03 – 8.48 |
| Volume | 101,693 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (CYCN)
Nexqual's technical model rates CYCN "BUY" based on 5 bullish and 2 bearish signals across 94 daily candles, as of September 8, 2026 at 06:23 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 76.59 (overbought) |
| vs SMA50 | Above (USD 3.29) |
| MACD | 0.19 (positive) |
From CYCN's Latest SEC 10-K Filing (filed 2026-03-30)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PHIO | Phio Pharmaceuticals Corp. | USD 1.08 | ▼ 4.42% |
| ELOX | Eloxx Pharmaceuticals, Inc. | USD 15 | ▼ 5.3% |
| PRFX | PRF Technologies Ltd. | USD 0.97 | ▼ 0.72% |
| XCUR | Exicure, Inc. | USD 1.25 | ▼ 3.1% |
| EDSA | Edesa Biotech, Inc. | USD 4.73 | ▼ 0.63% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:23 UTC. This page is informational and not investment advice.